SMSPHARMANSESMS Pharmaceuticals Limited· PharmaceuticalsMediumNegative
Announced Tue, 31 Mar · 19:01 IST

SMS Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed

Regulatory & Legal View source PDF

SMSPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.4%1-day move
₹372.60
prior close
₹393.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+2.4+1.8+0.6+4.4+4.4+4.4+7.3+10.9+11.9+6.3+10.0-3.7+10.2
Up moveDown movePending
AI summary

SMS Pharmaceuticals has received a tax demand of Rs. 7.19 crores from the Income Tax Department's Faceless Assessment Unit for Assessment Year 2018-19. The demand was raised under Section 156 of the Income Tax Act after the assessment officer added back certain income and disallowed deductions claimed under Section 35 of the Act. Separately, penalty proceedings under Section 270A have also been initiated for alleged under-reporting of income. The company has stated it is reviewing the order and plans to challenge it before the appropriate appellate forum. SMS Pharmaceuticals has clarified that, at this stage, there will be no material impact on its financial, operational, or other activities pending the review and appeal process.

Likely market impact

Investors should view this as a pending tax dispute rather than an immediate financial hit, but if the demand survives appeal, it will dent profits. The stock may see some short-term negativity due to the uncertainty around the outcome of the challenge.